{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:57:35Z","timestamp":1763765855050},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T00:00:00Z","timestamp":1283385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00428-010-0967-8","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T12:26:42Z","timestamp":1283344002000},"page":"521-527","source":"Crossref","is-referenced-by-count":15,"title":["Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas"],"prefix":"10.1007","volume":"457","author":[{"given":"Marco","family":"Volante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Marci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snezana","family":"Andrejevic-Blant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Tavaglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carla","family":"Sculli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Tampellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,2]]},"reference":[{"key":"967_CR1","first-page":"626","volume":"8","author":"A Pagani","year":"1995","unstructured":"Pagani A, Papotti M, Abbona GC, Bussolati G (1995) Chromogranin gene expression in colorectal adenocarcinomas. Mod Pathol 8:626\u2013632","journal-title":"Mod Pathol"},{"key":"967_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(1998100)186:2<151::AID-PATH154>3.0.CO;2-7","volume":"186","author":"G Abbona","year":"1998","unstructured":"Abbona G, Papotti M, Viberti L, Macr\u012d L, Stella A, Bussolati G (1998) Chromogranin A gene epression in non-small cell lung carcinomas. J Pathol 186:151\u2013156","journal-title":"J Pathol"},{"key":"967_CR3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.semdp.2009.12.003","volume":"27","author":"L Righi","year":"2010","unstructured":"Righi L, Sapino A, Marchi\u00f2 C, Papotti M, Bussolati G (2010) Neuroendocrine differentiation in breast cancer: established facts and unresolved problems. Semin Diagn Pathol 27:69\u201376","journal-title":"Semin Diagn Pathol"},{"key":"967_CR4","first-page":"1369","volume":"20","author":"E L\u00f3pez-Bonet","year":"2008","unstructured":"L\u00f3pez-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernad\u00f3 L, Menendez JA (2008) Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and imunohistochemical profiling. Oncol Rep 20:1369\u20131374","journal-title":"Oncol Rep"},{"key":"967_CR5","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/pros.21104","volume":"70","author":"A Berruti","year":"2010","unstructured":"Berruti A, Bollito E, Cracco CM, Volante M, Ciccone G, Porpiglia F, Papotti M, Scarpa RM, Dogliotti L (2010) The prognostic role of immunohistochemical chromogranin A expression in prostate cancer patients is significantly modified by androgen-deprivation therapy. Prostate 70:718\u2013726","journal-title":"Prostate"},{"key":"967_CR6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00000478-200608000-00003","volume":"30","author":"SX Jiang","year":"2006","unstructured":"Jiang SX, Mikami T, Umezawa A, Saegusa M, Kameya T, Okayasu I (2006) Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity. Am J Surg Pathol 30:945\u2013953","journal-title":"Am J Surg Pathol"},{"key":"967_CR7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2559.2005.02047.x","volume":"46","author":"MC Howe","year":"2005","unstructured":"Howe MC, Chapman A, Kerr K, Dougal M, Anderson H, Hasleton PS (2005) Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology 46:195\u2013201","journal-title":"Histopathology"},{"key":"967_CR8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00432-009-0544-1","volume":"135","author":"Y Segawa","year":"2009","unstructured":"Segawa Y, Takata S, Fujii M, Oze I, Fujiwara Y, Kato Y, Ogino A, Komori E, Sawada S, Yamashita M, Nishimura R, Teramoto N, Takashima S (2009) Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications. J Cancer Res Clin Oncol 135:1055\u20131059","journal-title":"J Cancer Res Clin Oncol"},{"key":"967_CR9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.breast.2003.11.008","volume":"13","author":"C Krimpen van","year":"2004","unstructured":"van Krimpen C, Elferink A, Broodman CA, Hop WC, Pronk A, Menke M (2004) The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study. Breast 13:329\u2013333","journal-title":"Breast"},{"key":"967_CR10","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/cncr.11376","volume":"97","author":"G Pelosi","year":"2003","unstructured":"Pelosi G, Pasini F, Sonzogni A, Maffini F, Maisonneuve P, Iannucci A, Terzi A, De Manzoni G, Bresaola E, Viale G (2003) Prognostic implications of neuroendocrine differentiation and hormone production in patients with stage I nonsmall cell lung carcinoma. Cancer 97:2487\u20132497","journal-title":"Cancer"},{"key":"967_CR11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/jcp.48.8.754","volume":"48","author":"M Mori","year":"1995","unstructured":"Mori M, Mimori K, Kamakura T, Adachi Y, Ikeda Y, Sugimachi K (1995) Chromogranin positive cells in colorectal carcinoma and transitional mucosa. J Clin Pathol 48:754\u2013758","journal-title":"J Clin Pathol"},{"key":"967_CR12","first-page":"201","volume":"18","author":"YB Cho","year":"2010","unstructured":"Cho YB, Yang SS, Lee WY, Song SY, Kim SH, Shin HJ, Yun SH, Chun HK (2010) The clinical significance of neuroendocrine differentiation in T3\u2013T4 node-negative colorectal cancer. Int J Surg Pathol 18:201\u2013206","journal-title":"Int J Surg Pathol"},{"key":"967_CR13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00042737-200104000-00018","volume":"13","author":"P Grabowsky","year":"2001","unstructured":"Grabowsky P, Schindler I, Anagnostopoulos I, Foss HD, RieckenEO MU, Stein H, Berger G, Buhr HJ, Scherubl H (2001) Neuroendocrine differentiation is a relevant prognostic factor in stage III\u2013IV colorectal cancer. Eur J Gastroenterol Hepatol 13:405\u2013411","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"967_CR14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00000478-200207000-00004","volume":"26","author":"J Shia","year":"2002","unstructured":"Shia J, Tickoo SK, Guillem JG, Qin J, Nissan A, Hoos A, Stojadinovic A, Ruo L, Wong WD, Paty PB, Weiser MR, Minsky BD, Klimstra DS (2002) Increased endocrine cells in treated rectal adenocarcinomas. A possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy. Am J Surg Pathol 26:863\u2013872","journal-title":"Am J Surg Pathol"},{"key":"967_CR15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00432-007-0234-9","volume":"133","author":"M Tampellini","year":"2007","unstructured":"Tampellini M, Brizzi MP, Bitossi R, Alabiso I, Sculli CM, Chiusa L, Papotti M, Dogliotti L (2007) Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy. J Cancer Res Clin Oncol 133:783\u2013785","journal-title":"J Cancer Res Clin Oncol"},{"key":"967_CR16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/386852a0","volume":"386","author":"M Borges","year":"1997","unstructured":"Borges M, Linnoila RI, van de Velde HJ, Chen H, Nelkin BD, Mabry M, Baylin SB, Ball DW (1997) An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 386:852\u2013855","journal-title":"Nature"},{"key":"967_CR17","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/modpathol.2008.39","volume":"21","author":"I Rapa","year":"2008","unstructured":"Rapa I, Ceppi P, Bollito E, Rosas R, Cappia S, Bacillo E, Porpiglia F, Berruti A, Papotti M, Volante M (2008) Human ASH1 expression in prostate cancer with neuroendocrine differentiation. Mod Pathol 21:700\u2013707","journal-title":"Mod Pathol"},{"key":"967_CR18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/0046-8177(92)90341-Y","volume":"23","author":"A Ooi","year":"1992","unstructured":"Ooi A, Hayashi H, Katsuda S, Nakanishi I (1992) Gastric carcinoma cells with endocrine differentiation show no evidence of proliferation. Hum Pathol 23:736\u2013741","journal-title":"Hum Pathol"},{"key":"967_CR19","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/1097-0142(19920601)69:11<2641::AID-CNCR2820691104>3.0.CO;2-L","volume":"69","author":"Y Hamada","year":"1992","unstructured":"Hamada Y, Oishi A, Shoji T, Takada H, Yamamura M, Hioki K, Yamamoto M (1992) Endocrine cells and prognosis in patients with colorectal carcinoma. Cancer 69:2641\u20132646","journal-title":"Cancer"},{"key":"967_CR20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ijc.2910540510","volume":"54","author":"AP Bruine De","year":"1993","unstructured":"De Bruine AP, Wiggers T, Beek C, Volovics A, von Meyenfeldt M, Arends JW, Bosman FT (1993) Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance. Int J Cancer 54:765\u2013771","journal-title":"Int J Cancer"},{"key":"967_CR21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF00192113","volume":"426","author":"S Ferrero","year":"1995","unstructured":"Ferrero S, Buffa R, Pruneri G, Siccardi AG, Pelagi M, Lee AK, Coggi G, Bosari S (1995) The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas. Virchows Arch 426:587\u2013592","journal-title":"Virchows Arch"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-010-0967-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-010-0967-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-010-0967-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T20:08:07Z","timestamp":1636315687000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-010-0967-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,2]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1007\/s00428-010-0967-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,2]]}}}